Registry recording heart artery disease and heart attacks at Barts Heart Centre
Observes patients with heart artery disease and heart attacks at Barts Heart Centre over time.
Plain-language title generated from the registry record
Registry title: Barts Revascularisation Registry
Key facts
- Where
- London, United KingdomSee the site
Where in United Kingdom
- Barts Health NHS TrustLondon, United KingdomTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Queen Mary University of London
- Trial code
- NCT05255705
- Record updated
- 5 October 2026
- Original description
Despite the year-on-year decrease, coronary artery disease (CAD) still remains one of the leading cause of mortality worldwide. With advances in technology and our understanding of cardiac disease, we can now treat CAD using minimally invasive interventional techniques. This has revolutionised treatment for and improved the lives of many patients with CAD. Although trials have assessed various therapeutic strategies in various populations, real-world evidence of intervention and medical treatment among patients with CAD is increasingly recognised as an important part of providing safety and efficacy data and improving the care we provide.Read full original descriptionShow less
Barts Revascularisation Registry - To Understand the Characteristics, Time-trends and Outcomes in Patients With Coronary Artery Disease at Barts Heart Centre
Despite the year-on-year decrease, coronary artery disease (CAD) still remains one of the leading cause of mortality worldwide. With advances in technology and our understanding of cardiac disease, we can now treat CAD using minimally invasive interventional techniques. This has revolutionised treatment for and improved the lives of many patients with CAD. Although trials have assessed various therapeutic strategies in various populations, real-world evidence of intervention and medical treatment among patients with CAD is increasingly recognised as an important part of providing safety and efficacy data and improving the care we provide.
This data will add to that literature by assessing the characteristics and outcomes of patients with CAD. It will also identify and characterise predictors of outcomes, improve risk stratification and diagnostic evaluation.
Inclusion: Informed consent will not be sought for, as patients are automatically included onto a database that we will use for research purposes; No children will be included in this study; Vulnerable adults or those unable to give consent will be included in the study as well if they are referred to the Interventional Cardiology team; Both male and female patients ≥16 years of age will be included; All patients will have had an angiogram at BHC; Any patient who has undergone revascularisation.
Exclusion: Patients <16 years will not be included in this study.